Abstract
Background: Faujasiopsis flexuosa (Lam.) C. Jeffrey. (FF) (Asteraceae) is traditionally used in the tropical island of Mauritius to manage several diseases including dysentery, asthma, and diabetes. Attempts have been made to validate its ethnopharmacological uses using both in vitro and in vivo approaches. Findings from in vitro studies have shown that FF possess antimicrobial, antioxidant, immunomodulatory and anti-diabetic properties.
Objective: This mini-review attempts to present recent scientific data on the pharmacological potential of FF and aims at extending knowledge on its ethnopharmacological applications, botanical description and phytochemical profile to the scientific community. Conclusion: Limited documentation of in vivo assays of this plant demonstrates an urgent need for extensive research in order to validate traditional uses and open new avenues for drug development.Keywords: Anti-diabetic, anti-microbial, Faujasiopsis flexuosa, immunomodulatory, medicinal plant, phytochemicals.
Current Traditional Medicine
Title:Faujasiopsis flexuosa (Lam.) C. Jeffrey (Asteraceae) – A Promising Traditionally used Endemic Medicinal Plant from Mauritius
Volume: 3 Issue: 2
Author(s): Marie Carene N. Picot and Fawzi M. Mahomoodally*
Affiliation:
- Department of Health Sciences, Faculty of Science, University of Mauritius, Réduit,Mauritius
Keywords: Anti-diabetic, anti-microbial, Faujasiopsis flexuosa, immunomodulatory, medicinal plant, phytochemicals.
Abstract: Background: Faujasiopsis flexuosa (Lam.) C. Jeffrey. (FF) (Asteraceae) is traditionally used in the tropical island of Mauritius to manage several diseases including dysentery, asthma, and diabetes. Attempts have been made to validate its ethnopharmacological uses using both in vitro and in vivo approaches. Findings from in vitro studies have shown that FF possess antimicrobial, antioxidant, immunomodulatory and anti-diabetic properties.
Objective: This mini-review attempts to present recent scientific data on the pharmacological potential of FF and aims at extending knowledge on its ethnopharmacological applications, botanical description and phytochemical profile to the scientific community. Conclusion: Limited documentation of in vivo assays of this plant demonstrates an urgent need for extensive research in order to validate traditional uses and open new avenues for drug development.Export Options
About this article
Cite this article as:
Carene N. Picot Marie and Mahomoodally M. Fawzi *, Faujasiopsis flexuosa (Lam.) C. Jeffrey (Asteraceae) – A Promising Traditionally used Endemic Medicinal Plant from Mauritius, Current Traditional Medicine 2017; 3 (2) . https://dx.doi.org/10.2174/2215083803666170510114254
DOI https://dx.doi.org/10.2174/2215083803666170510114254 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Environmental Tobacco Smoke Exposure and Airway Hyperresponsiveness
Inflammation & Allergy - Drug Targets (Discontinued) Biodegradable Hydrogel Bead of Casein and Modified Xanthan Gum for Controlled Delivery of Theophylline
Current Drug Therapy Treatment of Hypertensive Complications in Pregnancy
Current Pharmaceutical Design Anaphylaxis: An Update on its Understanding and Management
Recent Patents on Inflammation & Allergy Drug Discovery Immunotoxicity of Metal Oxide and Metal Nanoparticles and Animal Models to Evaluate Immunotoxicity of Nanoparticles
Current Bionanotechnology (Discontinued) Human Endotoxemia as a Model of Systemic Inflammation
Current Medicinal Chemistry The Main Receptors Involved in the COVID-19: A Systematic Review and Meta-Analysis
Current Medicinal Chemistry Strategies to Convert PACAP from a Hypophysiotropic Neurohormone Into a Neuroprotective Drug
Current Pharmaceutical Design The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications
Current Pharmaceutical Design Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design Automated Electrophysiology in Drug Discovery
Current Pharmaceutical Design Advances of Knowledge on Allergic Inflammation and the Oral Mucosa
Recent Patents on Inflammation & Allergy Drug Discovery Challenges in Current Drug Delivery from the Potential Application of Pharmacogenomics and Personalized Medicine in Clinical Practice
Current Drug Delivery Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity
Current Respiratory Medicine Reviews Design, Synthesis and Antihistamine Evaluations of Several N-hydroxyalkyl Desloratadine Analogues
Medicinal Chemistry SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management
Infectious Disorders - Drug Targets Spontaneous (Autoimmune) Chronic Urticaria in Children: Current Evidences, Diagnostic Pitfalls and Therapeutic Management
Recent Patents on Inflammation & Allergy Drug Discovery The Acute Phase Protein α1-Acid Glycoprotein: A Model for Altered Glycosylation During Diseases
Current Protein & Peptide Science Regulatory T Cells and Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued)